Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era

Documenti analoghi

• Recent advances in liver transplantation with HCV seropositive donors
  di: Murag, Soumya, et al.
  Pubblicazione: (2019)
• Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals
  di: Yoo, Eric R., et al.
  Pubblicazione: (2017)
• Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
  di: Gadiparthi, Chiranjeevi, et al.
  Pubblicazione: (2018)
• Short-Term Outcomes of Deceased Donor Renal Transplants of HCV Uninfected Recipients from HCV Seropositive Non-viremic donors and Viremic Donors in the Era of Direct-Acting Antivirals
  di: Hoz, Ricardo M. La, et al.
  Pubblicazione: (2019)
• Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
  di: Cholankeril, George, et al.
  Pubblicazione: (2017)